Citi Raises Price Target On Universal American (UAM)

Citi Investment Research has a Buy rating and is raising its price target on Universal American UAM to $22 from $19. In the research report, Citi writes, "After CVS pays $13 / share for the PDP segment, the market is valuing the remaining Universal business at around $7.45 per share. As Universal noted in its press release, the remaining business will have cash and statutory capital of $640 million at the end of 2010, or $8 per share. Universal will need less than $400 million of statutory capital to support its remaining revenue, by our calculation, suggesting there's more than $200 million ($2.50 per share) in capital that can be deployed to shareholders, on top of the ongoing earnings stream of the business, which we estimate at around $0.75 per share. Our price target rises from $19 to $22." Shares of UAM gained $5.84 on Friday to close at $20.45, a gain of nearly 40%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsCiti Investment ResearchHealth CareManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!